Sample | Title | Value | Rank |
GSM451635 | M15 - infected MBT/Pas fibroblasts (9 h post inf) | 309 | 85 |
GSM451636 | M16 - infected MBT/Pas fibroblasts (9 h post inf) | 344.7 | 87 |
GSM451637 | M17 - infected MBT/Pas fibroblasts (9 h post inf) | 275.2 | 84 |
GSM451632 | M11 - non-infected MBT/Pas fibroblasts | 557.8 | 91 |
GSM451633 | M12 - non-infected MBT/Pas fibroblasts | 495.8 | 90 |
GSM451634 | M13 - non-infected MBT/Pas fibroblasts | 666.3 | 92 |
GSM451629 | B15 - infected BALB/cByJ fibroblasts (9 h post inf) | 298.3 | 85 |
GSM451630 | B16 - infected BALB/cByJ fibroblasts (9 h post inf) | 194 | 79 |
GSM451631 | B17 - infected BALB/cByJ fibroblasts (9 h post inf) | 230.7 | 81 |
GSM451626 | B11 - non-infected BALB/cByJ fibroblasts | 410.2 | 88 |
GSM451627 | B12 - non-infected BALB/cByJ fibroblasts | 323.4 | 85 |
GSM451628 | B13 - non-infected BALB/cByJ fibroblasts | 390.4 | 88 |